MARKET

AIM

AIM

HEMISPHERX BIO
AMEX

Real-time Quotes | Nasdaq Last Sale

1.840
-0.030
-1.60%
Closed 16:00 09/16 EDT
OPEN
1.810
PREV CLOSE
1.870
HIGH
1.890
LOW
1.810
VOLUME
53.29K
TURNOVER
--
52 WEEK HIGH
14.81
52 WEEK LOW
1.510
MARKET CAP
4.49M
P/E (TTM)
-0.2215
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AIM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AIM News

  • AIM ImmunoTech Names Ellen Lintal as New Chief Financial Officer
  • ACCESSWIRE.1d ago
  • AIM ImmunoTech Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City
  • ACCESSWIRE.4d ago
  • AIM ImmunoTech Announces Progress Toward Opening of Breast Cancer Study at Roswell Park Comprehensive Cancer Center
  • ACCESSWIRE.09/10 12:30
  • AIM ImmunoTech Inc. Announces its Name Change is Complete, Its New Website is Up and the Company Now Trades as Ticker Symbol 'AIM'
  • ACCESSWIRE.09/09 12:45

More

Industry

Biotechnology & Medical Research
+0.98%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About AIM

AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
More

Webull offers AIM ImmunoTech Inc (AIM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.